Skip NavigationSkip to Content

Cancer and Autism: How PTEN Mutations Degrade Function at the Membrane and Isoform Expression in the Human Brain

  1. Author:
    Jang,Hyunbum
    Chen, Jiaye
    Iakoucheva, Lilia M
    Nussinov,Ruth
  2. Author Address

    Computational Structural Biology Section, Frederick National Laboratory for Cancer Research in the Cancer Innovation Laboratory, National Cancer Institute, Frederick, MD 21702, U.S.A., Department of Psychiatry, University of California San Diego, La Jolla, CA 92093, U.S.A., Department of Psychiatry, University of California San Diego, La Jolla, CA 92093, U.S.A; Institute for Genomic Medicine, University of California San Diego, La Jolla, CA 92093, U.S.A., Computational Structural Biology Section, Frederick National Laboratory for Cancer Research in the Cancer Innovation Laboratory, National Cancer Institute, Frederick, MD 21702, U.S.A; Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel. Electronic address: NussinoR@mail.nih.gov.,
    1. Year: 2023
    2. Date: Dec 15
    3. Epub Date: 2023 11 05
  1. Journal: Journal of Molecular Biology
    1. 435
    2. 24
    3. Pages: 168354
  2. Type of Article: Article
  3. Article Number: 168354
  1. Abstract:

    Mutations causing loss of PTEN lipid phosphatase activity can promote cancer, benign tumors (PHTS), and neurodevelopmental disorders (NDDs). Exactly how they preferentially trigger distinct phenotypic outcomes has been puzzling. Here, we demonstrate that PTEN mutations differentially allosterically bias P loop dynamics and its connection to the catalytic site, affecting catalytic activity. NDD-related mutations are likely to sample conformations of the functional wild-type state, while sampled conformations for the strong, cancer-related driver mutation hotspots favor catalysis-primed conformations, suggesting that NDD mutations are likely to be weaker, and our large-scale simulations show why. Prenatal PTEN isoform expression data suggest exons 5 and 7, which harbor NDD mutations, as cancer-risk carriers. Since cancer requires more than a single mutation, our conformational and genomic analysis helps discover how same protein mutations can foster different clinical manifestations, articulates a role for co-occurring background latent driver mutations, and uncovers relationships of splicing isoform expression to life expectancy. Copyright © 2023. Published by Elsevier Ltd.

    See More

External Sources

  1. DOI: 10.1016/j.jmb.2023.168354
  2. PMID: 37935253
  3. PMCID: PMC10842829
  4. WOS: 001150167500001
  5. PII : S0022-2836(23)00465-5

Library Notes

  1. Fiscal Year: FY2023-2024
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel